From PCOS to PMOS: Why the Name Change Matters
- 3 days ago
- 1 min read
A major shift is happening in the world of women’s health. Polycystic Ovary Syndrome (PCOS) is being renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).
This change, recently published in The Lancet, comes after a global consensus from medical experts and patients alike. Why the shift? For years, the term "polycystic ovaries" was misleading—many women with the condition don't actually have cysts, and the name ignored the complex metabolic and hormonal factors at play.
Why the change is important:
Medical Accuracy: The term "polycystic" was often a misnomer, as many people with the condition do not actually have physical cysts.
A Whole-Body Approach: The new name emphasizes that this is a metabolic and endocrine condition affecting the entire body, from insulin levels to energy regulation.
Clearer Communication: Using "Metabolic" and "Endocrine" helps patients and healthcare providers focus on the underlying hormonal drivers rather than just reproductive symptoms.
At Align Health, we believe that understanding the "why" behind your health is the first step toward feeling your best. Whether it's PCOS or PMOS, we’re here to support your journey with evidence-based care.
Comments